Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

About Us » Core Group

The Core Group (CG) provides leadership and sets the strategic direction for the programs of the WGND. It facilitates and accelerates decision-making and acts as a catalyst for effective implementation of programs and initiatives developed by the membership.

The CG is composed of the WGND Co-Chairs, the Leaders of the WGND Subgroups and a WGND Community Representative. The WGND Secretariat works with the CG to implement the strategic direction and initiatives of the WGND, develop action items and manage and administer WGND programs and the membership.



co-chairs Barbara Laughon, PhD Office of the Director Division of Microbiology and Infectious Diseases
National Institute of Allergy & Infectious Diseases (NIH/NIAID)
Bethesda, MD, USA
co-chairs Mel Spigelman, MD Global Alliance for TB Drug Development
40 Wall Street 24th Floor
New York, NY 10005
USA
biology targets subgroup leader Thomas Dick Department of Microbiology
Yong Loo Lin School of Medicine
National University of Singapore
Petros C. Karakousis, M.D. Center for TB Research, Johns Hopkins University
Baltimore, MD, USA
candidates subgroup leader Barbara Laughon, PhD Office of the Director Division of Microbiology and Infectious Diseases
National Institute of Allergy & Infectious Diseases (NIH/NIAID)
Bethesda, MD, USA
Matt Price Harvard School of Public Health
Boston, MA, USA


Critical Knowledge and Tools Subgroup Leaders Jacques Grosset, MD Center for TB Research
Johns Hopkins Medicine
Baltimore, MD, USA
Tawanda Gumbo UT Southwestern Medical Center
Dallas, TX, USA


Clinical Trial Capacity Subgroup Leader Christian Lienhardt, MD, PhD Stop TB Partnership Secretariat
World Health Organization
Geneva, Switzerland
David McNeeley Medical Service Corporation International (MSCI)
New York, NY, USA


Community Representative Albert Makone
Harare, Zimbabwe


Wim Vandevelde Chair, European AIDS Treatment Group
Brussels, Belgium

Secretariat Cherise Scott, PhD, MPH Global Alliance for TB Drug Development
New York, NY, USA